Skip to main content
Top
Published in: Virology Journal 1/2011

Open Access 01-12-2011 | Research

Hepatitis B virus infection among different sex and age groups in Pakistani Punjab

Authors: Fawad Khan, Sulaiman Shams, Ihteshamud Din Qureshi, Muhmmad Israr, Hayat Khan, Muhammad Tahir Sarwar, Muhammad Ilyas

Published in: Virology Journal | Issue 1/2011

Login to get access

Abstract

Background

Hepatitis B virus (HBV) infection is a serious health problem in the developing countries including Pakistan. Various risk factors are responsible for the spread of this infectious disease. Prevalence of HBV infection in apparently suspected individual of Punjab province of Pakistan was analyzed during January 2008 to December 2010. Current study was aimed to investigate the epidemiology and risk factors of HBV infection.

Methodology

Four thousand eight hundred and ninety patients suffering from chronic liver disease were screened for the presence of HBV DNA using qualitative Real Time PCR methodology to confirm their status of infection. A predesigned standard questionnaire was filled for all the patients that included information about the possible risk factors.

Results

A total of 4890 ELISA positive patients were screened for Hepatitis B virus infection. Of these 3143 were positive for HBV, includes 68.15% males and 31.85% females. Male were observed to be more frequently infected as compared to the female with a positivity ratio of 2.14: 1. The rate of infection increases with the passage of time in the course of three years. Highest frequency of infection was found in the age of 21-30 was 34.93% followed by 23.83% in 31-40. Only (13.39%) were belonging to the age group 11-20 year. The rate of infection declines with increasing age as shown by age groups 41-50 (16.13%) and 51-60 (7.09%). While children aged 0-10 and very old >60 age groups were very less frequently 1.49% and 1.65% infected respectively. Important risk factors contributing to HBV spread include barber risk (23.60%), blood transfusion (4.04%), History of injection 26.19%, Reuse of syringes 26.60%, dental risk (11.20%) and surgical procedure (4.26%). Among the entire respondents trend sharing personal items was very common. History of injection, barber risk, surgery and dental procedure and reuse of syringes appear as major risk factors for the transmission.

Conclusion

Male were more frequently exposed to the risk factors as compared to female. Similarly the younger age group had high rate of infection as compared to the children's and the older age groups. Reuse of syringes', barber risk and History of injection were main risk identified during the present study. To lower HBV transmission rate Government should take aggressive steps towards massive awareness and vaccination programs to decrease the burden of HBV from the Punjab province of Pakistan.
Appendix
Available only for authorised users
Literature
1.
go back to reference Barker LF, et al.: Transmission of serum hepatitis. 1970. Journal of the American Medical Association 1996,276(10):841-844. 10.1001/jama.276.10.841CrossRefPubMed Barker LF, et al.: Transmission of serum hepatitis. 1970. Journal of the American Medical Association 1996,276(10):841-844. 10.1001/jama.276.10.841CrossRefPubMed
2.
go back to reference Pungpapong S, Kim WR, Poterucha JJ: Natural History of Hepatitis B Virus Infection: An Update for Clinicians. Mayo Clinical Procedures 2007, 82: 967-975. 10.4065/82.8.967CrossRef Pungpapong S, Kim WR, Poterucha JJ: Natural History of Hepatitis B Virus Infection: An Update for Clinicians. Mayo Clinical Procedures 2007, 82: 967-975. 10.4065/82.8.967CrossRef
3.
go back to reference Zuckerman AJ: Hepatitis Viruses. In Baron's Medical Microbiology. 4th edition. Edited by: Baron S, et al. Univ of Texas Medical Branch; 1996. ISBN 0-9631172-1-1 Zuckerman AJ: Hepatitis Viruses. In Baron's Medical Microbiology. 4th edition. Edited by: Baron S, et al. Univ of Texas Medical Branch; 1996. ISBN 0-9631172-1-1
4.
go back to reference Samuel D, Muller R, Alexande G: Educational Research, National Hepatitis B Virus Programme. Infect Dis 2004, 234: 221-332. Samuel D, Muller R, Alexande G: Educational Research, National Hepatitis B Virus Programme. Infect Dis 2004, 234: 221-332.
5.
go back to reference Jules L, Dienstag MD: Hepatitis B Virus Infection. N Engl J Med 2008, 359: 1486-500. 10.1056/NEJMra0801644CrossRef Jules L, Dienstag MD: Hepatitis B Virus Infection. N Engl J Med 2008, 359: 1486-500. 10.1056/NEJMra0801644CrossRef
6.
go back to reference Khan NU, Siddique L, Ali I, Iqbal A, Munir I, Rashid F, Ali S, Raziq F, Swati ZA: Prevalence of hepatitis B in the blood donors of NW.F.P and FATA regions and the current scenario of HBV infection in Pakistan. African Journal of Biotechnology 2010,9(37):6162-6166. Khan NU, Siddique L, Ali I, Iqbal A, Munir I, Rashid F, Ali S, Raziq F, Swati ZA: Prevalence of hepatitis B in the blood donors of NW.F.P and FATA regions and the current scenario of HBV infection in Pakistan. African Journal of Biotechnology 2010,9(37):6162-6166.
7.
go back to reference Lee WM: Hepatitis B virus infection. New England Journal of Medicine 1997, 337: 1733-45. 10.1056/NEJM199712113372406CrossRefPubMed Lee WM: Hepatitis B virus infection. New England Journal of Medicine 1997, 337: 1733-45. 10.1056/NEJM199712113372406CrossRefPubMed
8.
go back to reference Gust I, Crowe S: The global importance of viral hepatitis. Clin Trop Med Commun Dis 1986, 1: 281-301. Gust I, Crowe S: The global importance of viral hepatitis. Clin Trop Med Commun Dis 1986, 1: 281-301.
9.
go back to reference Hakim ST, Kazmi SU, Bagasra O: Seroprevalence of Hepatitis B and C Genotypes among Young Apparently Healthy Females of Karachi-Pakistan. Libyan J Med 2007. AOP: 071123 Hakim ST, Kazmi SU, Bagasra O: Seroprevalence of Hepatitis B and C Genotypes among Young Apparently Healthy Females of Karachi-Pakistan. Libyan J Med 2007. AOP: 071123
10.
go back to reference Hutin Y, Harpaz R, Drobeniue J, Melnic A, Ray C, Favorov M, et al.: Injections given in healthcare settings as a major source of acute hepatitis B in Moldova. Int J Epidemiol 1999, 28: 782-6. 10.1093/ije/28.4.782CrossRefPubMed Hutin Y, Harpaz R, Drobeniue J, Melnic A, Ray C, Favorov M, et al.: Injections given in healthcare settings as a major source of acute hepatitis B in Moldova. Int J Epidemiol 1999, 28: 782-6. 10.1093/ije/28.4.782CrossRefPubMed
11.
go back to reference Francisci D, Antonelli S, Preziosi R, Mecozzi F, Stagni G, Pauluzzi S: Risk factors for acute parentally transmitted viral hepatitis: a 20-year study. Eur J Epidemiol 1993, 9: 625-8.CrossRefPubMed Francisci D, Antonelli S, Preziosi R, Mecozzi F, Stagni G, Pauluzzi S: Risk factors for acute parentally transmitted viral hepatitis: a 20-year study. Eur J Epidemiol 1993, 9: 625-8.CrossRefPubMed
12.
go back to reference Haley RW, Fischer PR: Commercial tattooing as a potentially important source of hepatitis C infection. Medicine 2001, 80: 134-51. 10.1097/00005792-200103000-00006CrossRefPubMed Haley RW, Fischer PR: Commercial tattooing as a potentially important source of hepatitis C infection. Medicine 2001, 80: 134-51. 10.1097/00005792-200103000-00006CrossRefPubMed
13.
go back to reference Gibb DM, Goodall TD, Dunn DT, Healy M, Neave P, Cafferkey M, et al.: Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet 2000, 356: 904-7. 10.1016/S0140-6736(00)02681-7CrossRefPubMed Gibb DM, Goodall TD, Dunn DT, Healy M, Neave P, Cafferkey M, et al.: Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet 2000, 356: 904-7. 10.1016/S0140-6736(00)02681-7CrossRefPubMed
14.
go back to reference Gitlin N: Hepatitis B: diagnosis, prevention and treatment. Clinical Chemistry 1997, 43: 1500-6.PubMed Gitlin N: Hepatitis B: diagnosis, prevention and treatment. Clinical Chemistry 1997, 43: 1500-6.PubMed
15.
go back to reference Lauer GM, Walker BD: Hepatitis C virus infection. N Engl J Med 2001, 345: 41-52. 10.1056/NEJM200107053450107CrossRefPubMed Lauer GM, Walker BD: Hepatitis C virus infection. N Engl J Med 2001, 345: 41-52. 10.1056/NEJM200107053450107CrossRefPubMed
16.
go back to reference Usman HR, Akhtar S, Rahbar MH, Hamid S, Moattar T, Luby SP: Risk factors of acute hepatitis B in Karachi. Epidemiol Infect 2003, 130: 293-300. 10.1017/S0950268802008178PubMedCentralCrossRefPubMed Usman HR, Akhtar S, Rahbar MH, Hamid S, Moattar T, Luby SP: Risk factors of acute hepatitis B in Karachi. Epidemiol Infect 2003, 130: 293-300. 10.1017/S0950268802008178PubMedCentralCrossRefPubMed
17.
go back to reference Alam MM, Zaidi SZ, Malik SA, Shaukat S, Naeem A, Sharif S, Angez M, Butt JA: Molecular epidemiology of Hepatitis B virus genotypes in Pakistan. BMC Infectious Diseases 2007, 7: 115. 10.1186/1471-2334-7-115PubMedCentralCrossRefPubMed Alam MM, Zaidi SZ, Malik SA, Shaukat S, Naeem A, Sharif S, Angez M, Butt JA: Molecular epidemiology of Hepatitis B virus genotypes in Pakistan. BMC Infectious Diseases 2007, 7: 115. 10.1186/1471-2334-7-115PubMedCentralCrossRefPubMed
18.
go back to reference Naz S, Ahmad M, Asghar H: Prevalence of Hepatitis 'B' Among Combined Military Hospital (CMH) Muzaffarabad. International Journal Of Agriculture & Biology 2002,4(2):227-230. Naz S, Ahmad M, Asghar H: Prevalence of Hepatitis 'B' Among Combined Military Hospital (CMH) Muzaffarabad. International Journal Of Agriculture & Biology 2002,4(2):227-230.
19.
go back to reference Manzoor SA, Malik IA, Wuz T, et al.: Hepatitis B related chronic liver disease in Rawalpindi Islamabad. JCPSP 1997, 7: 43-6. Manzoor SA, Malik IA, Wuz T, et al.: Hepatitis B related chronic liver disease in Rawalpindi Islamabad. JCPSP 1997, 7: 43-6.
20.
go back to reference Moosa FA, Shaikh BA, Choudhry MS, Khan FW, Sultan N: Frequency of Hepatitis B and C in Pre-operative Elective Surgery. JLUMHS 2009.,8(02): Moosa FA, Shaikh BA, Choudhry MS, Khan FW, Sultan N: Frequency of Hepatitis B and C in Pre-operative Elective Surgery. JLUMHS 2009.,8(02):
21.
go back to reference Awan Z, Idrees M, Amin I, Butt S, Afzal S, Akbar H, Rehman I, Younas S, Shahid M, Lal A, Saleem S, Rauff B: Pattern and molecular epidemiology of Hepatitis B virus genotypes circulating in Pakistan. Infection, Genetics and Evolution 2010, 10: 1242-1246. 10.1016/j.meegid.2010.08.006CrossRefPubMed Awan Z, Idrees M, Amin I, Butt S, Afzal S, Akbar H, Rehman I, Younas S, Shahid M, Lal A, Saleem S, Rauff B: Pattern and molecular epidemiology of Hepatitis B virus genotypes circulating in Pakistan. Infection, Genetics and Evolution 2010, 10: 1242-1246. 10.1016/j.meegid.2010.08.006CrossRefPubMed
22.
go back to reference Zubair M, Anjum ZM, Zafar S, Shamaoon M, Balouch GR: Frequency of Hepatitits B virus infection among children with chronic liver disease. A.P.M.C 2010.,4(1): Lee WM: Hepatitis B virus infection. New England Journal of Medicine 1997, 337: 1733-45 Zubair M, Anjum ZM, Zafar S, Shamaoon M, Balouch GR: Frequency of Hepatitits B virus infection among children with chronic liver disease. A.P.M.C 2010.,4(1): Lee WM: Hepatitis B virus infection. New England Journal of Medicine 1997, 337: 1733-45
23.
go back to reference Nwokediuko CS: Risk Factors For Hepatitis B Virus Transmission In Nigerians. The Internet Journal of Gastroenterology 2010,10(1)::. Nwokediuko CS: Risk Factors For Hepatitis B Virus Transmission In Nigerians. The Internet Journal of Gastroenterology 2010,10(1)::.
24.
go back to reference Castolo MC, ndez-ruiz LH, Ibarra-robles IE, Rate IHFN, Pena JEL: Prevalence of Hepatitis B Virus Infection And Related Risk Factors In A Rural community of Mexico. Am J Trop Med Hyg 2001,65(6):759-763. Castolo MC, ndez-ruiz LH, Ibarra-robles IE, Rate IHFN, Pena JEL: Prevalence of Hepatitis B Virus Infection And Related Risk Factors In A Rural community of Mexico. Am J Trop Med Hyg 2001,65(6):759-763.
25.
go back to reference Ali SA, Donahue RMJ, Qureshi H, Vermund SH: Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis 2009,13(1):9-19. 10.1016/j.ijid.2008.06.019PubMedCentralCrossRefPubMed Ali SA, Donahue RMJ, Qureshi H, Vermund SH: Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis 2009,13(1):9-19. 10.1016/j.ijid.2008.06.019PubMedCentralCrossRefPubMed
26.
go back to reference Qureshi H, Arif A, Riaz K, Alam ES, Ahmed W, Mujeeb AS: Determination of risk factors for hepatitis B and C in male patients suffering from chronic hepatitis. BMC Research Notes 2009, 2: 212. 10.1186/1756-0500-2-212PubMedCentralCrossRefPubMed Qureshi H, Arif A, Riaz K, Alam ES, Ahmed W, Mujeeb AS: Determination of risk factors for hepatitis B and C in male patients suffering from chronic hepatitis. BMC Research Notes 2009, 2: 212. 10.1186/1756-0500-2-212PubMedCentralCrossRefPubMed
27.
go back to reference Alavian MS, Fallahian F, Lankarani BK: Comparison of Seroepidemiology and Transmission Modes of Viral Hepatitis B in Iran and Pakistan. Hepatitis Monthly 2007,7(4):233-238. Alavian MS, Fallahian F, Lankarani BK: Comparison of Seroepidemiology and Transmission Modes of Viral Hepatitis B in Iran and Pakistan. Hepatitis Monthly 2007,7(4):233-238.
28.
go back to reference Waheed Y, Rahat BT, Safi ZS, Qadri I: Epidemiological patterns and risk factors associated with hepatitis B virus in Pakistani population. Asian Biomedicine 2010, 4: 547-554. Waheed Y, Rahat BT, Safi ZS, Qadri I: Epidemiological patterns and risk factors associated with hepatitis B virus in Pakistani population. Asian Biomedicine 2010, 4: 547-554.
29.
go back to reference Janjua NZ, Nizamy MA: Knowledge and practices of barbers about hepatitis B and C transmission in Rawalpindi and Islamabad. J Pak Med Assoc 2004, 54: 116-9.PubMed Janjua NZ, Nizamy MA: Knowledge and practices of barbers about hepatitis B and C transmission in Rawalpindi and Islamabad. J Pak Med Assoc 2004, 54: 116-9.PubMed
Metadata
Title
Hepatitis B virus infection among different sex and age groups in Pakistani Punjab
Authors
Fawad Khan
Sulaiman Shams
Ihteshamud Din Qureshi
Muhmmad Israr
Hayat Khan
Muhammad Tahir Sarwar
Muhammad Ilyas
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2011
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-8-225

Other articles of this Issue 1/2011

Virology Journal 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.